The tp53 gene is being studied for its role in cancer, with research indicating it is more than a tumor suppressor. Mutations in the tp53 gene have been found to affect treatment response in lung cancer and may also impact the survival of bladder cancer patients. The gene's mutation is also associated with a higher risk of multiple cancers, although its role and potential as a target for treatment are still being explored.